Drug recall · October 12, 2022
Aminophylline Injection recall
Why: Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)
- Lots / codes
Lot: 30-137-DK Exp. 1 DEC. 2022
- Quantity
- 103,150 10 mL vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- Distributed in the United States and Puerto Rico.
- Initiated
- September 27, 2022 · Voluntary: Firm initiated
- Classified
- October 4, 2022
- Reported
- October 12, 2022
- Ended
- August 21, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aminophylline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.